Perrild H, Hansen J M, Skovsted L, Christensen L K
Clin Endocrinol (Oxf). 1983 Feb;18(2):139-42. doi: 10.1111/j.1365-2265.1983.tb03196.x.
Serum T4, T3, rT3 and T3 resin uptake (T3 RU) were measured before and after 7 days of treatment with either propranolol, alprenolol, sotalol, atenolol or metoprolol in hyperthyroid patients. We found a significant decrease in serum T3 after propranolol, alprenolol, atenolol and metoprolol but no change in the sotalol treated group. A significant increase in rT3 was found in the propranolol and alprenolol treated groups whereas a significant fall in rT3 was found in the atenolol and metoprolol treated groups. No change was found in the sotalol treated group. The changes observed in serum T3 and in rT3 could be explained by an inhibition of the 5'deiodinase enzyme by propranolol and alprenolol and an inhibition of both the 5'deiodinase and 5 deiodinase enzymes caused by atenolol and metoprolol.
对甲状腺功能亢进患者在使用普萘洛尔、阿普洛尔、索他洛尔、阿替洛尔或美托洛尔治疗7天前后测定血清T4、T3、反T3(rT3)和T3树脂摄取率(T3 RU)。我们发现,使用普萘洛尔、阿普洛尔、阿替洛尔和美托洛尔后血清T3显著降低,但索他洛尔治疗组无变化。在普萘洛尔和阿普洛尔治疗组中rT3显著升高,而在阿替洛尔和美托洛尔治疗组中rT3显著下降。索他洛尔治疗组无变化。血清T3和rT3中观察到的变化可以用普萘洛尔和阿普洛尔对5′-脱碘酶的抑制作用以及阿替洛尔和美托洛尔对5′-脱碘酶和5-脱碘酶的抑制作用来解释。